Cargando…

Avascular osteonecrosis in kidney transplant recipients: Risk factors in a recent cohort study and evaluation of the role of secondary hyperparathyroidism

Avascular osteonecrosis (AVN) is a bone complication that indicates poor functional prognosis. Modern immunosuppressive and steroid-sparing drugs have significantly lowered the occurrence of AVN after kidney transplantation (KT). However, recent data on its incidence rates and risk factors are lacki...

Descripción completa

Detalles Bibliográficos
Autores principales:	Felten, Renaud, Perrin, Peggy, Caillard, Sophie, Moulin, Bruno, Javier, Rose-Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386392/ https://www.ncbi.nlm.nih.gov/pubmed/30794689 http://dx.doi.org/10.1371/journal.pone.0212931

Ejemplares similares

Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab
por: Gautier-Vargas, Gabriela, et al.
Publicado: (2020)

Impaired P2Y12 inhibition by clopidogrel in kidney transplant recipients: results from a cohort study
por: Muller, Clotilde, et al.
Publicado: (2016)

COVID-19 in a kidney transplant recipient treated with eculizumab for atypical hemolytic uremic syndrome: a case report
por: Cognard, Noëlle, et al.
Publicado: (2021)

Persistence of SARS-CoV-2 antibodies in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021)

Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021)

Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine
por: Benotmane, Ilies, et al.
Publicado: (2021)

COVID-19 vaccination in kidney transplant recipients
por: Caillard, Sophie, et al.
Publicado: (2021)

Eculizumab for Thrombotic Microangiopathy Associated with Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
por: Lanfranco, Luca, et al.
Publicado: (2017)

Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study
por: Benotmane, Ilies, et al.
Publicado: (2022)

A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration
por: Benotmane, Ilies, et al.
Publicado: (2022)

Association of Post Transplantation Anaemia and Persistent Secondary Hyperparathyroidism with Diastolic Function in Stable Kidney Transplant Recipients
por: Hsu, Hon-Chun, et al.
Publicado: (2021)

Cell therapy for avascular osteonecrosis of femoral head
por: Aoyama, T, et al.
Publicado: (2009)

Avascular osteonecrosis mechanism – between osteoporosis and antiphospholipid syndrome
por: Negru, Anca Ruxandra, et al.
Publicado: (2014)

Femoroacetabular impingement mimicking avascular osteonecrosis on bone scintigraphy
por: Suarez, Juan Pablo, et al.
Publicado: (2016)

Autologous grafts in the treatment of avascular osteonecrosis of the femoral head
por: Marcarelli, Marco, et al.
Publicado: (2020)

Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients
por: Cruzado, Josep M., et al.
Publicado: (2017)

Autologous bone marrow grafting of avascular osteonecrosis before collapse
por: Hernigou, P
Publicado: (2001)

Vertebral Body Avascular Osteonecrosis: An Unusual Late Complication of Tracheostomy
por: Rozov, Alexander, et al.
Publicado: (2022)

Granulomatous Inflammation and Hypercalcemia in Patients With Severe Systemic Oxalosis
por: Perrin, Peggy, et al.
Publicado: (2021)

In Reply to “Letter Regarding ‘Granulomatous Inflammation and Hypercalcemia in Patients With Severe Systemic Oxalosis’”
por: Perrin, Peggy, et al.
Publicado: (2022)

Recent Trends in the Surgical Treatment of Secondary Hyperparathyroidism
por: Won, Ho-Ryun, et al.
Publicado: (2020)

Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2020)

Causes of hypercalcemia in renal transplant recipients: persistent hyperparathyroidism and others
por: Moyses-Neto, M., et al.
Publicado: (2021)

COVID-19 and kidney transplantation
por: Caillard, Sophie
Publicado: (2022)

Molecular evolution of the SARS-CoV-2 omicron BA.2 variant in kidney transplant recipients with prolonged viral shedding
por: Caillard, Sophie, et al.
Publicado: (2023)

Transitional changes in the incidence of hip osteonecrosis among renal transplant recipients()
por: Takao, Masaki, et al.
Publicado: (2020)

The Authors Reply
por: Duval, Anna, et al.
Publicado: (2019)

Aseptic-avascular osteonecrosis: local “silent inflammation” in the jawbone and RANTES/CCL5 overexpression
por: Lechner, Johann, et al.
Publicado: (2017)

Does Diabetes Mellitus Increase the Risk of Avascular Osteonecrosis? A Systematic Review and Meta-Analysis
por: Konarski, Wojciech, et al.
Publicado: (2022)

An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants
por: Caillard, Sophie, et al.
Publicado: (2020)

Effect of Parathyroidectomy on Metabolic Homeostasis in Primary Hyperparathyroidism
por: Frey, Samuel, et al.
Publicado: (2022)

Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes
por: Garrouste, Cyril, et al.
Publicado: (2016)

Increased serum protein levels by Yuanshi Shengmai Chenggu Tablet in treatment of avascular osteonecrosis of the femoral head
por: Zeng, Jianchun, et al.
Publicado: (2018)

A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients
por: Masset, Christophe, et al.
Publicado: (2022)

A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2022)

Management of pre-renal transplant secondary hyperparathyroidism: parathyroidectomy versus cinacalcet
por: Elhadedy, Muhammed Ahmed, et al.
Publicado: (2023)

Mesenchymal stromal cells for the treatment of steroid induced avascular osteonecrosis in children – a two year follow-up
por: Tzaribachev, N, et al.
Publicado: (2008)

Persistent hyperparathyroidism after preemptive kidney transplantation
por: Okada, Manabu, et al.
Publicado: (2023)

Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients
por: Charmetant, Xavier, et al.
Publicado: (2022)

Torque teno virus DNA load as a predictive marker of antibody response to a three-dose regimen of COVID-19 mRNA-based vaccine in lung transplant recipients
por: Gallais, Floriane, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vk81tignpqcms58f9n856n2nfd